SugarCRM Named to Constellation ShortList for B2C Marketing Automation for Small and Midsize Business for Second Year Running
The Sugar Market Solution is Honored for its Role in Building and Scaling Brand Awareness…
News
Yosh.AI Named Certified Delivery Partner for UJET and Google Cloud Contact Center Platform
Strategic Training Program Qualifies Global Partners to Deploy UJET’s Award-Winning Contact Center Platform SAN FRANCISCO–(BUSINESS…
Sam Fraenkel Joins Fiduciary Trust International as Coral Gables-Based Wealth Director
Organization Continues to Expand its Footprint in South Florida, Adding Professional with Expertise in Meeting…
Blessing Health targets smarter sepsis surveillance with Wolters Kluwer
POC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions…
Perfecto by Perforce Announces Flutter Support for Native Mobile Applications
Perfecto proudly supports Flutter Integration Testing so your apps can fly high with stellar app…
Ceapro Inc. Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate Update
– Company boasts highest second quarter sales to date; Q2 2022 sales of $5,500,000 vs…
SELLAS Life Sciences’ Highly Selective CDK9 Inhibitor, GFH009, Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Model of Neuroendocrine Prostate Cancer Cell Line
– Neuroendocrine Prostate Cancer is Growing Unmet Medical Need – NEW YORK, Aug. 24, 2022 (GLOBE…
Catalyst Pharmaceuticals To Participate in Citi’s 17th Annual BioPharma Conference
CORAL GABLES, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a…
Erasca to Host R&D Day with KOL Dr. David Hong on Lead Clinical Programs ERAS-007 and ERAS-601 in Advanced Solid Tumors
Virtual event on Wednesday, September 7 at 4:30 PM ET will feature key opinion leader…
Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies
• The National Screening Laboratory of Sanquin Blood Supply Foundation joins MosaiQ Innovator’s Circle JERSEY,…
Enlivex Announces Regulatory Clearance in Multiple Countries for Integration of Frozen Allocetra Formulation and Expansion of Patient Population in its Sepsis Phase II Clinical Trial
Sepsis Phase II protocol amendments have been cleared by regulatory authorities in Israel, Spain, and…
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects
VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Apellis Announces 24-Month Results Showing Increased Effects Over Time with Pegcetacoplan in Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA)
Pegcetacoplan treatment effect accelerated between months 18-24, demonstrating a robust reduction of GA lesion growth…
Immunovant to Host Investor Webcast to Announce Two New Indications for Batoclimab on September 7, 2022
NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Study Published in JHEP Reports Shows Efruxifermin Rapidly Improved Fibrosis in Cirrhotic NASH patients After 16 Weeks of Treatment
33% improved by one fibrosis stage without worsening of NASH; 25% of patients treated with…
Ayala Pharmaceuticals Selected to Present Efficacy and Tolerability Data on AL102 in Desmoid Tumors at the European Society for Medical Oncology (ESMO) 2022 Congress
Oral presentation will feature results from Part A of the Phase 2/3 RINGSIDE clinical study…
Assembly Biosciences to Host Webcast on August 31, 2022, Introducing Two New Research Programs Targeting Recurrent HSV-2 Infection and Transplant-Associated Herpesvirus Diseases
– Renowned virologist, Nobel laureate and Assembly Bio board member, Sir Michael Houghton, PhD, will…
CymaBay Therapeutics to Participate in B. Riley’s Mini PBC Symposium on August 24, 2022
NEWARK, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
New Science Technology Accelerates Patient Recruitment and Enrollment
Patient relationship management and contact center technology enables Science 37 to achieve significantly greater patient…
Repligen To Host Investor Day 2022
WALTHAM, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a leading innovator of…